Glenmark to raise INR12 billion
Glenmark Pharmaceuticals, a research-driven, global, integrated pharmaceutical, has said that it will raise INR12 billion.
Swiss commodities giant Glencore on Thursday announced this year's biggest initial public offering, saying it plans to enter the London and Hong Kong stock markets to raise between $9 billion and $11 billion.